In this renewal application, the overall objective of this established and successful multidisciplinary training program in Digestive Diseases continues to be to train qualified postdoctoral individuals (M.D., and/or Ph.D.) for academic careers in gastroenterology and hepatology. The grant includes 33 Full Faculty (a net increase of 3 faculty since the last renewal) from both clinical and basic science departments with two tracks for potential trainees: i) basic/disease oriented research;and ii) patient-oriented research. The basic/disease oriented research tract remains one of long-standing excellence with training opportunities in cell biology, cancer biology, neuromuscular sciences, and experimental surgery/transplantion [sic] research. Training in this track is strongly supported through interactions with the NIH funded Mayo Comprehensive Cancer Center and Departments of Biochemistry/Molecular Biology, Pharmacology, Immunology, and Physiology. The patient-oriented research tract, which has seen recent expansion, maintains training opportunities in epidemiology/outcomes, human trials, and also a new initiative that encompasses Obesity and Nutrition. Training in this track is strongly buttressed by a recently awarded NIH Clinical Translational Science Award to Mayo Clinic. New R01 funded faculty have been added in all the tracks;especially those with an emphasis on Pediatrics or Nutrition. We continue to request support for 5 postdoctoral trainees per year that are selected through objective and consensus-driven mechanisms from a very large and talented pool of M.D., PhD, or M.D./PhD candidates derived from a variety of clinical and basic disciplines. The overall success of the program continues to be outstanding with 70% of former trainees over the last 10 years maintaining staff appointments within academic medicine and a funding portfolio from this cohort that includes 7 new NIH grants. Our aggressive recruitment of both female and underrepresented minority candidates also continues, with 44 % of the candidates deriving from female or minority groups during the last 10 years. This approach is strengthened by increased faculty representation of females and underrepresented minorities. Thus, this well established training program remains nimble and innovative, thereby continuing to be highly successful in achieving its goal of training individuals for academic careers in gastroenterology and hepatology.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Densmore, Christine L
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Mayo Clinic, Rochester
United States
Zip Code
Rizvi, Sumera; Gores, Gregory J (2014) Molecular pathogenesis of cholangiocarcinoma. Dig Dis 32:564-9
Rizvi, Sumera; Gores, Gregory J (2014) Current diagnostic and management options in perihilar cholangiocarcinoma. Digestion 89:216-24
Hickey, Raymond D; Mao, Shennen A; Glorioso, Jaime et al. (2014) Fumarylacetoacetate hydrolase deficient pigs are a novel large animal model of metabolic liver disease. Stem Cell Res 13:144-53
Camilleri, Michael; Shin, Andrea; Busciglio, Irene et al. (2014) Genetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion. Am J Physiol Gastrointest Liver Physiol 307:G508-16
Acosta, Andres; Camilleri, Michael; Shin, Andrea et al. (2014) Association of melanocortin 4 receptor gene variation with satiation and gastric emptying in overweight and obese adults. Genes Nutr 9:384
Tabibian, James H; Lindor, Keith D (2014) Ursodeoxycholic acid in primary sclerosing cholangitis: if withdrawal is bad, then administration is good (right?). Hepatology 60:785-8
Razumilava, Nataliya; Gradilone, Sergio A; Smoot, Rory L et al. (2014) Non-canonical Hedgehog signaling contributes to chemotaxis in cholangiocarcinoma. J Hepatol 60:599-605
Acosta, Andres; Abu Dayyeh, Barham K; Port, John D et al. (2014) Recent advances in clinical practice challenges and opportunities in the management of obesity. Gut 63:687-95
Tabibian, James H; Enders, Felicity; Imam, Mohamad H et al. (2014) Association between serum IgE level and adverse clinical endpoints in primary sclerosing cholangitis. Ann Hepatol 13:384-9
Rizvi, Sumera; Mertens, Joachim C; Bronk, Steven F et al. (2014) Platelet-derived growth factor primes cancer-associated fibroblasts for apoptosis. J Biol Chem 289:22835-49

Showing the most recent 10 out of 115 publications